Methylene Blue
The Catalyst for Cellular Health, Energy, and Longevity
A legacy of healing and innovation
Methylene blue, first synthesized in 1876, holds a unique place in medical history as the first pharmaceutical to be included in the United States Pharmacopeia (USP), the gold standard for ensuring the quality and safety of medicines. Initially used as a dye, it was soon recognized for its therapeutic potential, becoming a groundbreaking treatment for malaria in the late 19th century. Since then, it has been employed in a variety of traditional medical applications, many of which continue to this day.
In U.S. hospitals, methylene blue remains a life-saving treatment for conditions such as cyanide poisoning, where it restores normal cellular respiration, and methemoglobinemia, a disorder in which hemoglobin cannot effectively release oxygen to tissues. Methylene blue acts as a reducing agent, converting methemoglobin back to its functional form, enabling efficient oxygen transport.
Disruption of Cellular Respiration
Disruption of Cellular Respiration
Antiparasitic Activity
Antiparasitic Activity
Production of Reactive Oxygen Species (ROS)
Production of Reactive Oxygen Species (ROS)
Biofilm Penetration
Biofilm Penetration
Selective Toxicity
Selective Toxicity
Immune Modulation
Immune Modulation
Why Methylene Blue?
- Cognitive Enhancement
- Energy Optimization
- Anti-Aging Benefits
- Immune Support
- Regenerative Wellness
![](https://radenwellness.com/wp-content/uploads/2024/12/Untitled-design-1-2.png)